The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women

OBJECTIVE: To evaluate the effect of estrogen replacement therapy on cognitive functioning. METHODS: The study consisted of two 3-month treatment periods, one with estrogen and one with the placebo, in random order, separated by a 1-month wash-out period. The study group comprised 70 healthy postmenopausal women, aged 47-65 years, with previous hysterectomy. Sixty-two women completed the study. Cognitive speed and accuracy, attention, and memory were evaluated. Serum estradiol (E2) and FSH levels were controlled at the end of the estrogen, placebo, and wash-out periods. RESULTS: Most of the cognitive tests correlated with age: older women were slower and made more errors than younger women. Estrogen replacement therapy was not superior to the placebo in any test of cognitive performance. In two out of ten visual detection tasks, recognition thresholds were longer with estrogen than with the placebo (P < .001 and P = .004). On the most demanding test of working memory, the reaction times (P = .045) and error rates (P = .043) differed between treatments, yet this finding proved to be an effect of learning rather than treatment. There was no correlation between cognitive performance and serum E2 levels. CONCLUSION: Cognitive performance decreased with age. Short-term estrogen replacement therapy did not provide any advantage over the placebo in terms of improving the performance.

This article has been cited by other articles:

				N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand Dementia Prevention: Methodological Explanations for Inconsistent Results Epidemiol. Rev., November 1, 2008; 30(1): 35 - 66. [Abstract] [Full Text] [PDF]

				L. T Shuster, B. S Gostout, B. R Grossardt, and W. A Rocca Prophylactic oophorectomy in premenopausal women and long-term health Menopause Int, September 1, 2008; 14(3): 111 - 116. [Abstract] [Full Text] [PDF]

				P. Alhola, P. Polo-Kantola, R. Erkkola, and R. Portin Estrogen therapy and cognition: A 6-year single-blind follow-up study in postmenopausal women. Neurology, August 22, 2006; 67(4): 706 - 709. [Abstract] [Full Text] [PDF]

				Cognition and Dementia Obstet. Gynecol., October 1, 2004; 104(4_suppl): 25S - 40S. [Full Text] [PDF]

				S. R. Rapp, M. A. Espeland, S. A. Shumaker, V. W. Henderson, R. L. Brunner, J. E. Manson, M. L. S. Gass, M. L. Stefanick, D. S. Lane, J. Hays, et al. Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial JAMA, May 28, 2003; 289(20): 2663 - 2672. [Abstract] [Full Text] [PDF]

				B. B. Sherwin Estrogen and Cognitive Functioning in Women Endocr. Rev., April 1, 2003; 24(2): 133 - 151. [Abstract] [Full Text] [PDF]

				K.-A. Phillips and J. Bernhard Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions J Natl Cancer Inst, February 5, 2003; 95(3): 190 - 197. [Abstract] [Full Text] [PDF]

				H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan Postmenopausal Hormone Replacement Therapy: Scientific Review JAMA, August 21, 2002; 288(7): 872 - 881. [Abstract] [Full Text] [PDF]

				L. J. Tivis, S. J. Nixon, and M. D. Green Estrogen Replacement Therapy: A Perspective on Cognitive Impact Assessment, December 1, 2001; 8(4): 403 - 416. [Abstract] [PDF]

				S. A. de Moraes, M. Szklo, D. Knopman, and E. Park Prospective Assessment of Estrogen Replacement Therapy and Cognitive Functioning: Atherosclerosis Risk in Communities Study Am. J. Epidemiol., October 15, 2001; 154(8): 733 - 739. [Abstract] [Full Text] [PDF]

				K. Yaffe, K. Krueger, S. Sarkar, D. Grady, E. Barrett-Connor, D. A. Cox, T. Nickelsen, and The Multiple Outcomes of Raloxifene Evaluation Inv Cognitive Function in Postmenopausal Women Treated with Raloxifene N. Engl. J. Med., April 19, 2001; 344(16): 1207 - 1213. [Abstract] [Full Text] [PDF]

				E. S. LeBlanc, J. Janowsky, B. K. S. Chan, and H. D. Nelson Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis JAMA, March 21, 2001; 285(11): 1489 - 1499. [Abstract] [Full Text] [PDF]

				M Petri Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy Lupus, March 1, 2001; 10(3): 222 - 226. [Abstract] [PDF]

				R. STRICKLER, D. W. STOVALL, D. MERRITT, W. SHEN, M. WONG, and S. L. SILFEN Raloxifene and Estrogen Effects on Quality of Life in Healthy Postmenopausal Women: A Placebo-Controlled Randomized Trial Obstet. Gynecol., September 1, 2000; 96(3): 359 - 365. [Abstract] [Full Text] [PDF]

				M. M. Rice, A. B. Graves, S. M. McCurry, L. E. Gibbons, J. D. Bowen, W. C. McCormick, and E. B. Larson Postmenopausal Estrogen and Estrogen-Progestin Use and 2-Year Rate of Cognitive Change in a Cohort of Older Japanese American Women: The Kame Project Arch Intern Med, June 12, 2000; 160(11): 1641 - 1649. [Abstract] [Full Text] [PDF]

				A. J. Lerner Women and Alzheimer's Disease J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1830 - 1834. [Full Text]

				G. C. DAVIES, W. J. HUSTER, Y. LU, L. PLOUFFE Jr, and M. LAKSHMANAN Adverse Events Reported by Postmenopausal Women in Controlled Trials With Raloxifene Obstet. Gynecol., April 1, 1999; 93(4): 558 - 565. [Abstract] [Full Text] [PDF]

				Short-Term ERT Not Beneficial for Cognition? Journal Watch Psychiatry, July 1, 1998; 1998(701): 17 - 17. [Full Text]

				Short-Term ERT Not Beneficial for Cognition? Journal Watch (General), May 14, 1998; 1998(514): 3 - 3. [Full Text]